These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Interaction between erythrocytes and a perfluorochemical blood substitute. Tuliani VV; O'Rear EA; Fung BM; Sierra BD J Biomed Mater Res; 1988 Jan; 22(1):45-61. PubMed ID: 3343257 [TBL] [Abstract][Full Text] [Related]
5. Collateral oxygenation of the ischemic myocardium: the effect of viscosity and oxygen carrying fluorocarbons. Faithfull NS; Fennema M; Essed CE; Erdmann W; Jeekel H; Lapin R Prog Clin Biol Res; 1983; 122():229-36. PubMed ID: 6878365 [No Abstract] [Full Text] [Related]
6. [Rheology of stored erythrocyte concentrates in plasma substitutes]. Koerner K; Barras JP; Jung T Beitr Infusionsther; 1988; 21():43-8. PubMed ID: 2463012 [No Abstract] [Full Text] [Related]
7. [A comparative study of the effects of hemodilution with dextran and fluorocarbon emulsion on the changes in blood viscosity and collateral flow during myocardial ischemia]. Ma XL; Zhao RR; Zang YM; Wang FZ Yao Xue Xue Bao; 1987 Sep; 22(9):641-4. PubMed ID: 2451396 [No Abstract] [Full Text] [Related]
8. [Hemorheologic studies on intravenous infusion of perfluorocarbon blood substitute in monkeys (author's transl)]. Ding XC; Jiang HX; Cao WJ; Wang GF; Chen F Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):38-41. PubMed ID: 6211902 [No Abstract] [Full Text] [Related]
10. Changes in viscosity of low shear rates and viscoelastic properties of oxidative erythrocyte suspensions. Chung TW; Ho CP Clin Hemorheol Microcirc; 1999; 21(2):99-103. PubMed ID: 10599593 [TBL] [Abstract][Full Text] [Related]
11. In vitro alteration of hematological parameters and blood viscosity by the perfluorocarbon: Oxycyte. Arnaud F; Sanders K; Sieckmann D; Moon-Massat P Int J Hematol; 2016 May; 103(5):584-91. PubMed ID: 26886450 [TBL] [Abstract][Full Text] [Related]
12. Perflubron emulsion improves hepatic microvascular integrity and mitochondrial redox state after hemorrhagic shock. Paxian M; Keller SA; Huynh TT; Clemens MG Shock; 2003 Nov; 20(5):449-57. PubMed ID: 14560110 [TBL] [Abstract][Full Text] [Related]
14. Changes in brain pH, PO2, PCO2, cerebral blood flow, and blood gases induced by a hyperosmolar oxyreplete hemosubstitute during cardiopulmonary bypass. Briceño JC; Runge TM; McGinity JW; Frisbee SE; Ottmers SE; Korvick DL; Calhoon JH; Miller OL; Hantler CB; Cruzen OG; Ybarra JR; Howelton RV; Mireles RZ; Benson CK ASAIO J; 1997; 43(1):13-8. PubMed ID: 9116347 [TBL] [Abstract][Full Text] [Related]
15. Local oxygen supply of the myocardium after extreme hemodilution with Fluosol-DA. Kessler M; Vogel H; Günther H; Harrison DK; Höper J Prog Clin Biol Res; 1983; 122():237-48. PubMed ID: 6878366 [No Abstract] [Full Text] [Related]
16. Effect of perfluorodecalin on the microsomal mono-oxygenase system in perfused rat livers. Guaitani A; Villa P; Bartosek I Xenobiotica; 1983 Jan; 13(1):39-45. PubMed ID: 6858199 [TBL] [Abstract][Full Text] [Related]
17. Current status of artificial oxygen carriers. Spahn DR Adv Drug Deliv Rev; 2000 Feb; 40(3):143-51. PubMed ID: 10837786 [TBL] [Abstract][Full Text] [Related]
18. Blood substitutes: has the right solution been found? Lancet; 1986 Mar; 1(8483):717-8. PubMed ID: 2870227 [No Abstract] [Full Text] [Related]
19. [Current aspects in red blood cell substitutes]. Wang Y; Pan J; Yu Y Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164 [TBL] [Abstract][Full Text] [Related]